technetium tc 99m mertiatide has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y | 1 |
| Bhatt, RI; Clarke, NW; Montague, RJ; Ramani, VA; Samuel, JD | 1 |
2 other study(ies) available for technetium tc 99m mertiatide and Bladder Cancer
| Article | Year |
|---|---|
FDG PET/CT and renal scan demonstrations of carcinoma in the urinary bladder and bladder diverticulum.
Topics: Diverticulum; Fluorodeoxyglucose F18; Humans; Kidney; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Technetium Tc 99m Mertiatide; Tomography, X-Ray Computed; Urinary Bladder; Urinary Bladder Neoplasms | 2013 |
The natural history of postoperative renal function in patients undergoing ileal conduit diversion for cancer measured using serial isotopic glomerular filtration rate and 99m technetium-mercaptoacetyltriglycine renography.
Topics: Adult; Aged; Aged, 80 and over; Colonic Neoplasms; Creatinine; Cystectomy; Glomerular Filtration Rate; Humans; Kidney; Middle Aged; Postoperative Period; Radiography; Radioisotope Renography; Radiopharmaceuticals; Technetium Tc 99m Mertiatide; Urinary Bladder Neoplasms; Urinary Diversion; Urologic Diseases | 2006 |